metoprolol has been researched along with Embryopathies in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Resch, B | 1 |
| Papp, G | 1 |
| Molnár, GB | 1 |
| Kertész, E | 1 |
| Csanády, M | 1 |
1 other study available for metoprolol and Embryopathies
| Article | Year |
|---|---|
Control and long-term inhibition of foetal supraventricular tachyarrhythmia with a cardioselective beta-receptor blocker administered to the mother.
Topics: Adult; Female; Fetal Diseases; Humans; Infant; Infant, Newborn; Maternal-Fetal Exchange; Metoprolol; | 1988 |